NeuroMedica is a Delaware C-Corp commercializing an endovascular flow diverter for cerebral aneurysms. Our patented IP was licensed from Cornell, and preliminary development work underwritten by the Helmsley Charitable Trust. The inventor of the Sphere, and our CMO, Howard Riina, MD, treated Leona Helmsley and she reciprocated with philanthropy. The regulatory path and exit strategy have strong supporting evidence.